arrow
N

Nisha Sharma

Leeds Teaching Hospitals NHS Trust
H指数:28
被引数:3,096

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vacuum-assisted biopsy in the era of low-risk ductal carcinoma in situ active monitoring: real world data and implications

真空辅助活检在低风险导管原位癌主动监测时代:真实世界数据及意义

2025-10-240
OAAI
Impact of artificial intelligence-assisted colonoscopy on gastroenterology fellow performance: A pragmatic randomized controlled trial

人工智能辅助结肠镜检查对消化内科住院医师表现的影响:一项实用性随机对照试验

2025-09-270
PRE
Discrepancy between mammographic and pathological sizing of screen-detected DCIS: Risk factors and impact on ipsilateral recurrence rates

钼靶检查与病理学检查对筛查发现的DCIS大小评估的差异:风险因素及其对同侧复发率的影响

2025-09-030
PRE
Assessing artificial intelligence in breast screening with stratified results on 306 839 mammograms across geographic regions, age, breast density and ethnicity: A Retrospective Investigation Evaluating Screening (ARIES) study

评估人工智能在乳腺筛查中的应用,并通过分层结果分析306 839份乳腺X光片,涵盖地理区域、年龄、乳腺密度和种族差异:一项评估筛查的回顾性调查(ARIES)研究

2025-05-140
OA
NOSTRA-Feasibility: Predicting pathological complete response using multiple ultrasound-guided tumour bed core biopsies after neoadjuvant systemic therapy in HER-2 positive ER negative breast cancer

NOSTRA-Feasibility:在新辅助系统治疗后,通过多次超声引导的肿瘤床核心活检预测HER-2阳性ER阴性乳腺癌的病理完全缓解

BREAST
IF7.9
2025-02-010
OAAI
Diagnostic performance of tomosynthesis plus synthetic mammography versus full-field digital mammography with or without tomosynthesis in breast cancer screening: A systematic review and meta-analysis

断层合成联合合成乳腺x线摄影与全视野数字乳腺x线摄影在乳腺癌筛查中的诊断性能: 系统评价和荟萃分析

2024-10-120
OAAI
Vacuum-assisted excision: a safe minimally invasive option for benign phyllodes tumor diagnosis and treatment-a systematic review and meta-analysis
2024-05-140
OAAI
Overview of Axillary Treatment in Early Breast Cancer: patient-level meta-analysis of long-term outcomes among 20,273 women in 29 randomised trials
2024-05-020
PRE
SMALL: Open Surgery versus Minimally invasive vacuum-Assisted excision for smaLL screen-detected breast cancer - a UK phase III randomised multi-centre trial
2024-05-020
PRE
European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO (vol 50, 107292, 2024)]

由EUSOMA,EUSOBI,ESP (BWG) 和ESSO共同制定的具有不确定的恶性潜能的乳腺病变 (B3病变) 的诊断,治疗和随访的欧洲指南 (vol 50,107292,2024)]

EJSO
IF2.9
2024-03-010
OAAI